Heparin Beyond Anticoagulation in Sepsis – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Patricia C Liaw et al, adding:
“The evolving role of heparin in sepsis: therapeutic potential in the age of immunothrombosis
Sepsis is marked by immunothrombosis, where inflammation, coagulation, endothelial injury, platelet activation, and NET formation drive both large and small vessel occlusion.
Heparin has re-emerged as a candidate because its actions reach beyond anticoagulation to anti-inflammatory, antimicrobial, and NET-modulating effects.
Trial evidence is limited, and COVID-19 data hint at benefit early and possible harm in advanced disease.”
Title: The evolving role of heparin in sepsis: therapeutic potential in the age of immunothrombosis
Authors: Patricia C Liaw, Ryan Zarychanski, Patrick R Lawler, Sylvain A Lother, Asher A Mendelson
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 3, 2026, 13:42Immune Thrombocytopenia: Moving Beyond Platelet Counts Toward Durable Remission
-
Aug 3, 2026, 13:28Aboo Shama Khan: Pulmonary Embolism – A Medical Emergency Every Nurse Must Recognize
-
Aug 3, 2026, 13:08Ashwin Patel: Evaluating Red Cell Function Post-Treatment in SCD Patients
-
Aug 3, 2026, 13:03Mohamed El Belghiti Alaoui: The Promise of AAV Gene Therapy in Hemophilia A
-
Aug 3, 2026, 12:44Replaying the CSL Symposium on Gene Therapy Durability in Haemophilia – EAHAD
-
Aug 3, 2026, 12:43Shinta C: Takeda Marks a Milestone in Hemophilia Care
-
Aug 3, 2026, 12:37Deepak Kumar Dasmohapatra: Honored for Contributions to Transfusion Medicine and Immunohematology by the Governor of Chhattisgarh
-
Aug 3, 2026, 12:30Furkan Bahar: Thrombotic and Hemorrhagic Risk Profiles in Advanced Melanoma – Targeted vs Immune Combination Therapies
-
Aug 3, 2026, 12:28Tayyaba Iftikhar: When Platelets Talk to Cancer Cells